Analyzing Therapeutics MD's FY 2023 Financial Results
Friday, 29 March 2024, 20:21
Therapeutics MD FY 2023 Financial Results
Therapeutics MD reported a net loss from continuing operations of $7.7 million for FY 2023. The company's cash and equivalents totaled $4.3 million.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.